Galectin Therapeutics director Harold Shlevin purchases $7,539 in common stock By Investing.com
Marcel Trisent
12/31/2024
Get Curated Post Updates!
Sign up for my newsletter to see new photos, tips, and blog posts.
Sign up for my newsletter to see new photos, tips, and blog posts.